An Oral Cancer Research Center (OCRC) is proposed that will focus on gaining an understanding, at the molecular level, of the factors- that control the invasive behavior of oral squamous cell carcinoma (SCC). This neoplasm is characterized by relentless invasion and growth. SCC cells infiltrate into adjacent tissues, degrading basement membranes and extracellular matrix, often disrupting tissue architecture and frequently engendering lymph node involvement and distant metastasis. Cellular activities that lead to invasion include growth factor-induced cell locomotion, interactions of extracellular matrix macromolecules with their receptors, and elaboration of matrix-degrading enzymes. The proposed Center comprises four research laboratories at the University of California, San Francisco that have considerable experience in defining molecules related to tumor invasion. Moreover, this group already established synergistic approaches to the analysis of the complex issues related to highly intricate and sequential processes like invasion. Project I studies the role of basement membrane laminins and cell-surface receptors in promoting cell invasion by disruption of the tumor-suppressor cadherin molecules. Project II addresses the importance of the alphav class of integrin receptors, which bind interstitial connective tissue molecules, in regulating cell growth and invasion. Project III explores regulation of proteinase expression promoted by growth factors produced in response to stromal-SCC invasion. Project IV studies the role of hyaluronic acid and the CD44 receptor in modulating tumor invasion by oral SCC. In addition, two pilot projects will examine (1) genetic alterations in oral SCC, using a new cytogenetic method (comparative genomic hybridization), and (2) the role of extracellular matrix tenascin and its receptor (alpha-v-beta-6) in progression of oral SCC, using receptor-null mice. The Center includes Administrative, Biostatistics, and Histopathology Cores to support the research efforts. It is anticipated that this diverse set of investigators assembled in a highly interactive and interdependent collective will advance our understanding of the underlying biological principles that govern the process of tumor invasion by oral SCC. Finally, although beyond the immediate scope of this proposal, advances in our basic knowledge in this area will suggest development of appropriate treatment modalities for invasive SCC.

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
Specialized Center (P50)
Project #
5P50DE011912-04
Application #
2897108
Study Section
Special Emphasis Panel (ZDE1-YS (13))
Project Start
1996-09-30
Project End
2001-07-31
Budget Start
1999-09-21
Budget End
2000-07-31
Support Year
4
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Anatomy/Cell Biology
Type
Schools of Dentistry
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Bortoluzzi, Marcelo C; Yurgel, Liliane S; Dekker, Nusi P et al. (2004) Assessment of p63 expression in oral squamous cell carcinomas and dysplasias. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 98:698-704
Sethi, Neerja; Palefsky, Joel (2003) Treatment of human papillomavirus (HPV) type 16-infected cells using herpes simplex virus type 1 thymidine kinase-mediated gene therapy transcriptionally regulated by the HPV E2 protein. Hum Gene Ther 14:45-57
Stern, Robert; Shuster, Svetlana; Neudecker, Birgit A et al. (2002) Lactate stimulates fibroblast expression of hyaluronan and CD44: the Warburg effect revisited. Exp Cell Res 276:24-31
Mio, Kazuhiro; Stern, Robert (2002) Inhibitors of the hyaluronidases. Matrix Biol 21:31-7
Regezi, Joseph A; Ramos, Daniel M; Pytela, Robert et al. (2002) Tenascin and beta 6 integrin are overexpressed in floor of mouth in situ carcinomas and invasive squamous cell carcinomas. Oral Oncol 38:332-6
Nicoll, Steven B; Barak, Ory; Csoka, Antonei B et al. (2002) Hyaluronidases and CD44 undergo differential modulation during chondrogenesis. Biochem Biophys Res Commun 292:819-25
Shuster, Svetlana; Frost, Gregory I; Csoka, Antonei B et al. (2002) Hyaluronidase reduces human breast cancer xenografts in SCID mice. Int J Cancer 102:192-7
Mio, K; Csoka, A B; Nawy, S S et al. (2001) Detecting hyaluronidase and hyaluronidase inhibitors. Hyaluronan-substrate gel and -inverse substrate gel techniques. Methods Mol Biol 171:391-7
Lin, G; Stern, R (2001) Plasma hyaluronidase (Hyal-1) promotes tumor cell cycling. Cancer Lett 163:95-101
Nawy, S S; Csoka, A B; Mio, K et al. (2001) Hyaluronidase activity and hyaluronidase inhibitors. Assay using a microtiter-based system. Methods Mol Biol 171:383-9

Showing the most recent 10 out of 32 publications